Printer Friendly
The Free Library
4,659,290 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Aethlon device shown to reverse immune suppression in cancer.


Researchers have found that a blood filter made by Aethlon Medical Inc. was able to remove the immunosuppressive Immunosuppressive
Any agent that suppresses the immune response of an individual.

Mentioned in: Antirheumatic Drugs, Graft-vs.-Host Disease, Immunosuppressant Drugs


immunosuppressive

1. pertaining to or inducing immunosuppression.

2.
 activity normally found in the fluid of cancer patients, the company said Nov. 19.

Aethlon said it recently discovered the Hemopurifier, which separates viruses and other toxins from the blood, efficiently captures tumor-secreted exosomes that inhibit the ability of the immune system immune system

Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders.
 to combat cancer.

In follow-on studies, led by Dr. Douglas Taylor at the University of Louisville See also
  • The University of Louisville Cardinal Singers
  • The University of Louisville Collegiate Chorale
  • History of Louisville, Kentucky
  • McConnell Center
References

1. ^ [1]
2. ^ [2] URL accessed on June 8 2006
3.
 in Kentucky, it was demonstrated that the capture of exosomes by the Hemopurifier resulted in reversing immunosuppressive activity. The activity in ovarian cancer patients is known to correlate with disease progression and long-term survival.

"Based on emerging data, we envision the Hemopurifier will become a treatment standard that enhances the benefit of therapies administered to those who suffer from cancer," said James Joyce, chairman and chief executive officer of Aethlon Medical, in a prepared statement. The annual size of the cancer treatment market is estimated to exceed $43 billion.

The Hemopurifier is being developed in the United States as a countermeasure for bioterrorism and, internationally, as a treatment for naturally evolving pandemic pandemic /pan·dem·ic/ (pan-dem´ik)
1. a widespread epidemic of a disease.

2. widely epidemic.


pan·dem·ic
adj.
Epidemic over a wide geographic area.

n.
 threats and chronic infectious diseases such as hepatitis C and HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. , the AIDS virus. The device's technology mimics natural immune response and is compatible with portable pumps and dialysis machines.

Aethlon stock is traded over-the-counter as AEMD AEMD Automotive Electric Motor Drive (US Department of Energy program) . It has traded between 22 cents and 88 cents during the past 52 weeks.

Send biotechnology industry-related news to Heather Chambers, hchambers@ sdbj.com, or call (858)277-6359, ext. 3125.
COPYRIGHT 2007 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:BIOTECH; Aethlon Medical Inc.- blood filter
Author:Chambers, Heather
Publication:San Diego Business Journal
Article Type:Brief article
Date:Dec 3, 2007
Words:255
Previous Article:In other North County news.(Business in the North County)(Brief article)
Next Article:Pharmaceutical-grade peptide manufacturer acquires local firm.(BIOTECH)(PolyPeptide Laboratories Group)(NeoMPS Inc)(Isochem)(Brief article)
Topics:



Related Articles
AETHLON MEDICAL SIGNS MAUFACTURING PARTNERSHIP.(with Pharmaceutical Systems Inc.)(Brief Article)
INDIA AND CII SUPPORT AETHLON HIV/HEPATITIS TRIALS.
AETHLON MEDICAL LAUNCHES HEPATITIS-C CLINICAL TRIAL.
AETHLON EXPANDS DEVICE APPPICATIONS TO INCLUDE CANCER.
AETHLON MEDICAL TO SUBMIT BIOSHIELD IDE.
ATHELON HEMOPURIFIER REMOVES MORE THAN 99% OF DENGUE VIRUS.
Aethlon & Uncle Sam partner.(BIOTECH)(Brief article)
Aethlon Medical Expands Cancer Research Initiative.
AETHLON ANNOUNCES BIRD FLU RESEARCH COLLABORATIONS.
AETHLON FILES PATENT ON HEMOPURIFIER USE FOR BIOMARKERS.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles